SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

ABBV: EU Approves MAVIRET

AbbVie's MAVIRET is approved by the European Commission for people with acute Hepatitis C Virus infection

ABBV

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.